IN2014MU00675A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00675A
IN2014MU00675A IN675MU2014A IN2014MU00675A IN 2014MU00675 A IN2014MU00675 A IN 2014MU00675A IN 675MU2014 A IN675MU2014 A IN 675MU2014A IN 2014MU00675 A IN2014MU00675 A IN 2014MU00675A
Authority
IN
India
Prior art keywords
preparation
relates
present
dabigatran etexilate
acid addition
Prior art date
Application number
Other languages
English (en)
Inventor
Vijayavitthal Thippannachar Mathad
Pavankumar Vrajlal Solanki
Sekhar Babu Uppelli
Ganesh Gitaram Sarode
Original Assignee
Megafine Pharma P Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megafine Pharma P Ltd filed Critical Megafine Pharma P Ltd
Priority to IN675MU2014 priority Critical patent/IN2014MU00675A/en
Priority to PCT/IN2015/000100 priority patent/WO2015128875A2/en
Publication of IN2014MU00675A publication Critical patent/IN2014MU00675A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pyrrole Compounds (AREA)
IN675MU2014 2014-02-26 2015-02-23 IN2014MU00675A (sl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN675MU2014 IN2014MU00675A (sl) 2014-02-26 2015-02-23
PCT/IN2015/000100 WO2015128875A2 (en) 2014-02-26 2015-02-23 A process for preparation of dabigatran etexilate mesylate and intermediates thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN675MU2014 IN2014MU00675A (sl) 2014-02-26 2015-02-23

Publications (1)

Publication Number Publication Date
IN2014MU00675A true IN2014MU00675A (sl) 2015-10-23

Family

ID=53267425

Family Applications (1)

Application Number Title Priority Date Filing Date
IN675MU2014 IN2014MU00675A (sl) 2014-02-26 2015-02-23

Country Status (2)

Country Link
IN (1) IN2014MU00675A (sl)
WO (1) WO2015128875A2 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105732433A (zh) * 2016-04-13 2016-07-06 山东新华制药股份有限公司 达比加群酯中间体缩合物的精制方法
CN110878083A (zh) * 2018-09-05 2020-03-13 连云港恒运药业有限公司 一种达比加群酯中间体的纯化方法
CN111690699A (zh) * 2020-05-19 2020-09-22 浙江工业大学 一种酶促在线合成3-(吡啶-2-氨基)丙羟肟酸的方法
CN114113346B (zh) * 2020-08-25 2024-01-12 石药集团恩必普药业有限公司 一种达比加群酯原料药或制剂中对甲苯磺酸乙酯、对甲苯磺酸异丙酯的检测方法
CN114716411B (zh) * 2022-04-29 2024-03-15 天方药业有限公司 一种从生产母液中回收制备甲磺酸达比加群酯的方法
CN115417855A (zh) * 2022-09-22 2022-12-02 安徽美诺华药物化学有限公司 一种达比加群酯甲磺酸盐的合成工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
US20050107409A1 (en) * 2003-03-10 2005-05-19 Boehringer Ingelheim International Gmbh Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
EP1609784A1 (de) 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005025728A1 (de) 2005-06-04 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester
ITTO20050486A1 (it) 2005-07-14 2005-10-13 Dumitru Bucuresteanu Compressore ad aria funzionante a elica continua in un tubo girevole
DE102006054005A1 (de) 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
CZ305085B6 (cs) * 2008-03-14 2015-04-29 Zentiva, K.S. Způsob přípravy dabigatranu
CZ2008669A3 (cs) 2008-10-24 2010-05-05 Zentiva, A. S. Zpusob prípravy dabigatranu a jeho meziprodukty
HUP1100244A2 (hu) 2011-05-11 2012-11-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Gyógyszeripari intermedierek és eljárás elõállításukra
EP2522662A1 (en) * 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers

Also Published As

Publication number Publication date
WO2015128875A3 (en) 2015-11-12
WO2015128875A2 (en) 2015-09-03

Similar Documents

Publication Publication Date Title
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
IN2014CH00247A (sl)
IN2014MU00675A (sl)
EA039598B9 (ru) Соединение, нацеленное на ил-23а и фно-альфа, и его применение
WO2014192030A3 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
IN2013MU00646A (sl)
IN2014MU00455A (sl)
IN2014CH00840A (sl)
PH12016501613B1 (en) Pyrazines modulators of gpr6
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
IN2014CH00304A (sl)
IN2013MU01113A (sl)
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
MX2019003584A (es) Proceso para la preparacion de la forma i de anhidrato de boscalid y la forma ii de anhidrato de boscalid.
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
IL250260A0 (en) Process for preparing 4,5,6-trichloropicolinic acid
MY173051A (en) Microorganism having producing ability of quinolinic acid and method for producing quinolinic acid using the microorganism
IN2013CH05865A (sl)
IN2014CH01391A (sl)
MX361888B (es) Un procedimiento mejorado para producir zilpaterol.
IN2013MU02843A (sl)
WO2017037743A3 (en) Dabigatran etexilate 1,4-butanedisulfonate salt and its crystal form
IN2013MU03466A (sl)